↓ Skip to main content

Dove Medical Press

Lurasidone for the treatment of bipolar depression: an evidence-based review

Overview of attention for article published in Neuropsychiatric Disease and Treatment, August 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

policy
0 policy sources
twitter
2 X users
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
24 Dimensions

Readers on

mendeley
86 Mendeley
Title
Lurasidone for the treatment of bipolar depression: an evidence-based review
Published in
Neuropsychiatric Disease and Treatment, August 2015
DOI 10.2147/ndt.s50961
Pubmed ID
Authors

Rachel Franklin, Sam Zorowitz, Andrew K Corse, Alik S Widge, Thilo Deckersbach

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Unknown 85 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 14%
Other 11 13%
Student > Bachelor 11 13%
Student > Doctoral Student 6 7%
Student > Ph. D. Student 6 7%
Other 20 23%
Unknown 20 23%
Readers by discipline Count As %
Medicine and Dentistry 29 34%
Psychology 9 10%
Pharmacology, Toxicology and Pharmaceutical Science 7 8%
Nursing and Health Professions 3 3%
Chemistry 3 3%
Other 9 10%
Unknown 26 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2023.
All research outputs
#7,856,238
of 25,584,565 outputs
Outputs from Neuropsychiatric Disease and Treatment
#985
of 3,120 outputs
Outputs of similar age
#83,916
of 276,761 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#24
of 91 outputs
Altmetric has tracked 25,584,565 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 3,120 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 67% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 276,761 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.
We're also able to compare this research output to 91 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.